top of page

Events

The ISCBI runs informal workshops every year at different locations around the world and also now hosts regular on-line symposia and workshops to discuss a broad range of emerging issues and latest developments relevant to pluripotent stem cell banking. To access post-meeting information including recordings, power points and summary reports contact admin@iscbi.org    

 

We welcome new collaborations including training activities in the broadest applications of pluripotent stem cells. Contact admin@iscbi.org or glyn.stacey@iscbi.org

ISCBI-hPSCreg Training Webinar Series on Donor and Stem Cell Data

The following webinars are planned for 2024. 

1. Stem Cell Terminologies, Date to be confirmed 

  • Principles of established stem cell terminologies and ontogenies (Stefanie Seltmann, Fraunhofer IBMT) 

  • Stem cell characterisation data management (Christine Wells, University of Melbourne, Australia, TBC) 

  • Data management of image analysis in cell culture (Mike Shaw, National Physics Laboratory, UK)

  • Cell characterisation data management (Rajewsky, Max Delbruch Centre, Germany)

  • Case study from TC276 ISO Standard on Stem, Cell Data Interoperability (Yong Zhang, ISO TC276 Standards WG5 committee).

  • TC276 ISO Standard on Stem Cell Data Interoperability (Yong Zhang, Southern Medical Hospital, China).

​

2. Donor and stem cell line data management, April 2024

ISCBI Webinar in collaboration with hPSCreg: Cross border data transfer: real-life experiences.

  • Introduction to the training series: Dr Glyn Stacey, International Stem Cell Banking Initiative.

  • Introduction to chairs: Prof Andreas Kurtz, Fraunhofer-IBMT and TBC

  • Presentations on experiences in translating donor/cell line data across borders: (10min max plus 2min Q&A each)

Dr Tenneille Ludwig, WiCell, USA

Dr Rachel Steeg, EBiSC and hPScreg experience, Fraunhofer-IBMT, Germany.

Dr Hyunyoung Kim, KNIH, Korea

Dr YJ Peng, CAS, China,

  • Audience Q&A with Panel members 15min.

  • Panel discussion on key elements of a road map for data control, 20mins

  • Chair summary and session close

  • ISCBI convener announces future webinars and meeting close.

​

3. AI Tools for Stem Cell Data Utility, date to be confirmed

  • Interrogating stem cell data (Nancy Mah, Fraunhofer IBMT)

  • AI Manufacturing (speaker TBC),

  • AI for stem cell research (Christine Wells, University of Melbourne, Australia)

  • Ethical issues to be addressed in the use of AI (speaker TBC)

  • QA of integrated approaches: insilico plus in vitro (Barry Hardy, Edelweiss)

ISCBI Meeting in collaboration with HaploiPS

​

Venue: Zoom (TBC, Hamburg, Germany)

Sunday 14th July 2024

09:00-16:00 CET

(08:00-15:00 UK BST)

Draft agenda:

​

International Efforts in Stem Cell Standardisation

Introduction and welcome GS/AK/RI

08:45 - Welcome and ISCBI Update. Glyn Stacey, ISCBI and BISCRM/CAS, UK.

09:00 - ISCI discussion on genetic stability in hPSCs. Martin Pera, ISCI lead and Jackson Labs, USA.

10:30 - Refreshment break

10:45 - ISCBI session chaired by Glyn Stacey and Andreas Kurtz

  • ISSCR best practice standards. Tenneille Ludwig, Wicell, USA

  • NIST/SCB Carl potency assays for cell based products. Carl Simon NIST, USA (virtual TBC)

  • The Haploipsc programme and perspectives on the need for stem cell standards. Anna Veiga, Idibell, Spain.

  • Good practice for generation of hPSC-derived organoids. David Pamies, Univ Lauzanne, Switzerland.

  • A brief introduction to the ECVAM stem cell initiative. Lucia Aspiroz, ECVAM, European Commission, Italy.

11:45 - Discussion on current needs for stem cell standards

12:15 - Lunch

13:00 - EU HaploiPSC session. Chairs, Anna Veiga (Idibell, Spain) and Gerald Schumann (PEI, Germany).

Draft introductory talks

  • The role of EUTCD in delivery of EU hPSCs as starting materials, Anna Veiga, 10mins

  • The delivery of hPSC-based products under EU regulations, G Schumann, 10mins

  • Finding, comparing and assessing LIFCU lines (TBC).

  • 5 minute outlines of Haploipsc WG2 (Joel Glover), WG3 (Andreas Kurtz) and WG4 (Gerald Schumann, Paul Ehlich Institute, Germany)

  • WG coordinator’s led discussion on key aspects of regulatory development of hPSC-based drug products (Panel: Gerald Schumann (PEI), Andras Dinnyes (Biolentum, Hungary), Andreas Kurtz (IBMT-Fraunhofer), Joel Glover (Norway) ).

15:30 - Closing remarks, ISCBI forward plan and farewell, Glyn Stacey.

16:00 - Meeting Ends

Sponsorship

The ISCBI is a not for profit organisation and welcomes sponsorship to support meetings, for collaborative projects and as donations towards delivery of our aims. There are different packages for sponsorship of individual meetings and we are happy to discuss support for other activities and interactions. Contact glyn.stacey@iscbi.org for further information.

bottom of page